TL
GILD icon

Tradewinds LLC’s Gilead Sciences GILD Stock Holding History

Tradewinds LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Sell
471
-3,965
-89% -$522K 0.2% 85
2026
Q1 		$584K Buy
4,436
+107
+2% +$15K 0.19% 72
2025
Q4 		$531K Sell
4,329
-238
-5% -$28.9K 0.13% 107
2025
Q3 		$507K Buy
+4,567
New +$519K 0.12% 111
2025
Q2 		– Sell
-4,537
Closed -$508K – 150
2025
Q1 		$508K Sell
4,537
-159
-3% -$16.4K 0.14% 115
2024
Q4 		$450K Sell
4,696
-490
-9% -$44.1K 0.13% 127
2024
Q3 		$435K Sell
5,186
-279
-5% -$21.3K 0.13% 120
2024
Q2 		$375K Buy
+5,465
New +$365K 0.12% 137
2023
Q3 		$429K Sell
5,727
-70
-1% -$5.38K 0.25% 68
2023
Q2 		$447K Buy
5,797
+121
+2% +$9.65K 0.26% 67
2023
Q1 		$471K Buy
+5,676
New +$470K 0.29% 67
2022
Q4 		– Sell
-5,577
Closed -$344K – 152
2022
Q3 		$344K Buy
5,577
+1,004
+22% +$63.3K 0.25% 78
2022
Q2 		$283K Buy
+4,573
New +$283K 0.19% 91

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tradewinds LLC's GILD Position: Q2 2026 in Review

Tradewinds LLC reduced its Gilead Sciences (GILD) stake by 89% in Q2 2026, selling an estimated $522K and leaving 471 shares worth $906K. The position accounts for 0.2% of the portfolio, ranked #85.

Tradewinds LLC first reported a position in GILD in Q2 2022 and has held it in 13 quarters since. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tradewinds LLC held 471 shares of Gilead Sciences worth $906K as of Q2 2026.
  • Tradewinds LLC sold 3,965 Gilead Sciences shares in Q2 2026, an estimated $522K.
  • Gilead Sciences made up 0.2% of Tradewinds LLC's portfolio in Q2 2026, its #85 holding.
  • Tradewinds LLC first reported a position in Gilead Sciences in Q2 2022 and has held it in 13 quarters since.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tradewinds LLC's 13F filing for Q2 2026, filed 14 Aug 2026.